China Digital Health Market Outlook to 2033 - Electronic Health Records, Regulatory Approved Apps and Telehealth
Summary
GlobalData’s “China Digital Health Market Outlook to 2033” is a comprehensive databook report, covering key market data on the China Digital Health market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Electronic Health Records, Regulatory Approved Apps and Telehealth
The China Digital Health Market report provides key information and data on -
Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
2023 company share and distribution share data for Digital Health Market.
Global corporate-level profiles of key companies operating within the China Digital Health Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.
Scope
China Digital Health is segmented as follows -
Electronic Health Records
Regulatory Approved Apps
Telehealth
Reasons to Buy
China Digital Health Market report helps you to develop -
Business strategies by identifying the key market segments poised for strong growth in the future.
Market-entry and market expansion strategies.
Design competition strategies by identifying who-stands-where in the market.
Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
Understand the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Digital Health Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Digital Health Market, China
3.1 Digital Health Market, China, Revenue ($m), 2018-2033
3.2 Digital Health Market, China, Revenue Mix ($m), 2023
3.3 Digital Health Market, China, Category Contribution by Revenue ($m), 2023
3.4 Digital Health Market, China, Revenue ($m), 2018-2033
3.5 Digital Health Market, China, Volume (Units), 2018-2033
3.6 Digital Health Market, China, Volume (Units), 2018-2033
3.7 Digital Health Market, China, Company Share by Revenue ($m), 2023
4 Electronic Health Records Market, China
4.1 Electronic Health Records Market, China, Revenue Mix ($m), 2023
4.2 Electronic Health Records Market, China, Segment Contribution (%), 2023
4.3 Electronic Health Records Market, China, Revenue ($m), 2018-2033
4.4 Electronic Health Records Market, China, Volume (Units), 2018-2033
4.5 Electronic Health Records Market, China, Average Price ($), 2018-2033
4.6 Electronic Health Records Market, China, Distribution Share by Revenue ($m), 2023
4.7 Electronic Health Records Market, China, Company Share by Revenue ($m), 2023
Table 29: Tibet Duo Rui Pharma to Acquire 51% Stake in Hongxi Medical Technology (Tianjin)
Table 30: GKHT Medical Technology to Acquire Remaining 17.2% Stake in Hunan Guoke Hengtai Medical Technology from Changsha Huizhong Enterprise Management Consulting for USD0.26 Million
Table 31: APT Pharma (China) to Acquire 19% Stake in Beijing Xinlejia International Health Technology from Mighty Century for USD2.2 Million
Table 32: Shanghai Rundu Biotechnology to Raise USD1.38 Million in Private Placement of Shares
Table 33: iFLYTEK to Spin off iFLYTEK Medical
Table 34: Guangzhou Fangxin Medical Technology Raises More than USD1.36 Million Equity Financing
Table 35: Shenzhen Zhong Ji Health Science and Sichuan Zhongji Guande Biotechnology to form Joint Venture with Sichuan Zhongnongyun Qihang Data Technology
Table 36: Sanyou Bio Enters into Co-Development Agremeent with BioGeometry
Table 37: Tianzhihang Plans to form Join Joint Venture Agreement with Beijing Ruihuachen Medical Technology
Table 38: SMK Enters into Licensing Agreement with Canary Speech
Table 39: InnoMax Medical Technology Enters into Licensing Agreement with Belluscura
Table 40: HitGen Enters into Agreement with Nested Therapeutics
Table 41: Beijing Touche Future Technology (Thorough Future) Secures USD13.8 Million in Series A+ Financing
Table 42: Kangyuan Medical Technology (Dalian) Raises Funds through Venture Financing
Table 43: Suzhou Aimi Life Science Technology (Amystron, AIMAISI and Aimi) Raises Funds through Angel Financing
Table 44: Cipher Gene (SafeGene) Raises USD13.8 Million Series C Financing